Abstract
The notion that tumors contain a population of cells termed cancer stem cells, or cancer initiating cells has been gaining momentum over the past several years. It is postulated that much like a normal organ in the body, tumors contain a population of stem cells which are responsible for driving tumor growth, invasion and metastasis. This becomes of paramount clinical importance because our present therapies often times shrink tumors, but do not prevent their recurrence or metastatic spread. This behavior of tumors suggests that a population of cells within the tumor capable of driving tumor growth is insensitive to our current therapies and survives to reestablish disease. Therefore, understanding the biology of the cancer stem cell which is believed responsible for this tumor re-growth, will allow targeted therapy to better treat cancers. This chapter reviews the cancer stem cell hypotheses, and investigates the potential sources for the cancer stem cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balkwill F and Mantovani A (2001) Inflammation and cancer: Back to Virchow? Lancet 357: 539–545
Rather JL (1978) The genesis of cancer: A study in the history of ideas. The Johns Hopkins University Press, Baltimore, MD
Ford CE, Hamerton JL, Barnes DW, et al. (1956) Cytological identification of radiation-chimaeras. Nature 177: 452–454
Marshak DR (2001) Introduction: Stem cell biology. CHSL Press, Woodbury, NY
Potten CS and Loeffler M (1990) Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110: 1001–1020
Siminovitch L, McCulloch EA and Till JE (1963) The distribution of colony-forming cells among spleen colonies. J Cell Physiol 62: 327–336
Spangrude GJ, Heimfeld S and Weissman IL (1988) Purification and characterization of mouse hematopoietic stem cells. Science 241: 58–62
Till JE and Mc CE (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14: 213–222
Pierce GB (1974) Neoplasms, differentiations and mutations. Am J Pathol 77: 103–118
Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988
Collins AT, Berry PA, Hyde C, et al. (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946–10951
Fang D, Nguyen TK, Leishear K, et al. (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65: 9328–9337
Gibbs CP, Kukekov VG, Reith JD, et al. (2005) Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia 7: 967–976
Sanai N, Alvarez-Buylla A and Berger MS (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353: 811–822
Singh SK, Clarke ID, Terasaki M, et al. (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821–5828
Singh SK, Hawkins C, Clarke ID, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396–401
Aractingi S, Kanitakis J, Euvrard S, et al. (2005) Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 65: 1755–1760
Barozzi P, Luppi M, Facchetti F, et al. (2003) Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med 9: 554–561
Chakraborty A, Lazova R, Davies S, et al. (2004) Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 34: 183–186
Golfinopouloss V, Pentheroudakis G, Kamakari S, et al. (2009) Donor-derived breast cancer in a bone marrow transplantation recipient. Breast Cancer Res Treat 113: 211–213
Houghton J, Stoicov C, Nomura S, et al. (2004) Gastric cancer originating from bone marrow-derived cells. Science 306: 1568–1571
Li H, Fan X, Kovi RC, et al. (2007) Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res 67: 10889–10898
Morath C, Rohmeiss P, Schwenger V, et al. (2005) Transmission of donor-derived small-cell carcinoma cells by a nontumor-bearing allograft. Transplantation 80: 540–542
Dome B, Timar J, Dobos J, et al. (2006) Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 66: 7341–7347
Ho JW, Pang RW, Lau C, et al. (2006) Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 44: 836–843
Kaplan RN, Riba RD, Zacharoulis S, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820–827
Karnoub AE, Dash AB, Vo AP, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557–563
Peters BA, Diaz LA, Polyak K, et al. (2005) Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11: 261–262
Macarthur M, Hold GL and El-Omar EM (2004) Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286: G515–520
El-Omar EM, Rabkin CS, Gammon MD, et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124: 1193–1201
Roberts RA and Kimber I (1999) Cytokines in non-genotoxic hepatocarcinogenesis. Carcinogenesis 20: 1397–1401
Tanaka Y, Furuta T, Suzuki S, et al. (2003) Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 187: 1822–1825
Bryder D, Rossi DJ and Weissman IL (2006) Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 169: 338–346
Morrison SJ and Kimble J (2006) Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441: 1068–1074
Sharpless NE and DePinho RA (2004) Telomeres, stem cells, senescence, and cancer. J Clin Invest 113: 160–168
Ruzankina Y, Pinzon-Guzman C, Asare A, et al. (2007) Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell stem cell 1: 113–126
Houghton J (2007) Bone-marrow-derived cells and cancer – an opportunity for improved therapy. Nature clinical practice 4: 2–3
Greten FR and Karin M (2004) The IKK/NF-kappaB activation pathway – a target for prevention and treatment of cancer. Cancer Lett 206: 193–199
Maeda A, Ebata T, Matsunaga K, et al. (2005) Primary liver cancer with bidirectional differentiation into hepatocytes and biliary epithelium. Journal of hepato-biliary-pancreatic surgery 12: 484–487
Droll L, Song YH, Krohn A, et al. (2008) TNFalpha protects tissue resident stem cells from H2O2 induced apoptosis through a novel NF-small ka, CyrillicB p50/p50 homodimer mediated signaling pathway. Biochem Biophys Res Commun 371: 626–629
Crisostomo PR, Wang Y, Markel TA, et al. (2008) Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294: C675–682
Kollias G, Douni E, Kassiotis G, et al. (1999) On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol Rev 169: 175–194
Leek RD, Landers R, Fox SB, et al. (1998) Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77: 2246–2251
Lejeune FJ, Ruegg C and Lienard D (1998) Clinical applications of TNF-alpha in cancer. Curr Opin Immunol 10: 573–580
Malik ST, Griffin DB, Fiers W, et al. (1989) Paradoxical effects of tumour necrosis factor in experimental ovarian cancer. Int J Cancer 44: 918–925
Malik ST, Naylor MS, East N, et al. (1990) Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur J Cancer 26: 1031–1034
O’Byrne KJ, Dalgleish AG, Browning MJ, et al. (2000) The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 36: 151–169
Grayson WL, Zhao F, Bunnell B, et al. (2007) Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 358: 948–953
Coussens LM and Werb Z (2002) Inflammation and cancer. Nature 420: 860–867
Faller G and Kirchner T (2005) Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch 446: 1–9
Whitcomb DC (2004) Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer. Am J Physiol Gastrointest Liver Physiol 287: G315–319
De Marzo AM, Nakai Y and Nelson WG (2007) Inflammation, atrophy, and prostate carcinogenesis. Urologic Oncology 25: 398–400
Cai X, Carlson J, Stoicov C, et al. (2005) Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 128: 1937–1952
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process – First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740
Fox JG and Wang TC (2007) Inflammation, atrophy, and gastric cancer. J Clin Invest 117: 60–69
Franco EL and Rohan TE (2002) Cancer precursors: Epidemiology, Detection and Prevention. Springer, New York
Hiratsuka S, Watanabe A, Aburatani H, et al. (2006) Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 8: 1369–1375
Olaso E, Salado C, Egilegor E, et al. (2003) Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37: 674–685
Olaso E, Santisteban A, Bidaurrazaga J, et al. (1997) Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26: 634–642
Bagri A, Gurney T, He X, et al. (2002) The chemokine SDF1 regulates migration of dentate granule cells. Development 129: 4249–4260
Ma Q, Jones D and Springer TA (1999) The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10: 463–471
Nagasawa T, Hirota S, Tachibana K, et al. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635–638
Kucia M, Ratajczak J and Ratajczak MZ (2005) Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biology of the cell/under the auspices of the European Cell Biology Organization 97: 133–146
Liles WC, Broxmeyer HE, Rodger E, et al. (2003) Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102: 2728–2730
Petit I, Szyper-Kravitz M, Nagler A, et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3: 687–694
Devine SM, Flomenberg N, Vesole DH, et al. (2004) Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin’s lymphoma. J Clin Oncol 22: 1095–1102
Helbig G, Christopherson KW, 2nd, Bhat-Nakshatri P, et al. (2003) NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631–21638
Schioppa T, Uranchimeg B, Saccani A, et al. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198: 1391–1402
Franitza S, Kollet O, Brill A, et al. (2002) TGF-beta1 enhances SDF-1alpha-induced chemotaxis and homing of naive T cells by up-regulating CXCR4 expression and downstream cytoskeletal effector molecules. Eur J Immunol 32: 193–202
Bachelder RE, Wendt MA and Mercurio AM (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203–7206
Yonezawa A, Morita R, Takaori-Kondo A, et al. (2003) Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells. J Virol 77: 3777–3784
Iikura M, Miyamasu M, Yamaguchi M, et al. (2001) Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 70: 113–120
Jourdan P, Vendrell JP, Huguet MF, et al. (2000) Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J Immunol 165: 716–724
Wysoczynski M, Reca R, Ratajczak J, et al. (2005) Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 105: 40–48
Chan KK, Oza AM and Siu LL (2003) The statins as anticancer agents. Clin Cancer Res 9: 10–19
Schmidmaier R, Baumann P, Simsek M, et al. (2004) The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase. Blood 104: 1825–1832
Christopherson KW, 2nd, Hangoc G, Mantel CR, et al. (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305: 1000–1003
Janowska-Wieczorek A, Marquez LA, Dobrowsky A, et al. (2000) Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp Hematol 28: 1274–1285
Kijowski J, Baj-Krzyworzeka M, Majka M, et al. (2001) The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 19: 453–466
Kucia M, Jankowski K, Reca R, et al. (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35: 233–245
Peled A, Kollet O, Ponomaryov T, et al. (2000) The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 95: 3289–3296
Libura J, Drukala J, Majka M, et al. (2002) CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100: 2597–2606
Dontu G, Al-Hajj M, Abdallah WM, et al. (2003) Stem cells in normal breast development and breast cancer. Cell Prolif 36 (Suppl 1): 59–72
Geminder H, Sagi-Assif O, Goldberg L, et al. (2001) A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 167: 4747–4757
Hall JM and Korach KS (2003) Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17: 792–803
Jankowski K, Kucia M, Wysoczynski M, et al. (2003) Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 63: 7926–7935
Muller A, Homey B, Soto H, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50–56
Porcile C, Bajetto A, Barbero S, et al. (2004) CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann NY Acad Sci 1030: 162–169
Sun YX, Wang J, Shelburne CE, et al. (2003) Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89: 462–473
Kollet O, Shivtiel S, Chen YQ, et al. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 112: 160–169
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Li, H., Stoicov, C., Fan, X., Cerny, J., Houghton, J.M. (2009). The Chronically Inflamed Microenvironment and Cancer Stem Cells. In: Dittmar, T., Zanker, K. (eds) Stem Cell Biology in Health and Disease. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3040-5_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-3040-5_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3039-9
Online ISBN: 978-90-481-3040-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)